Cargando…
On-Demand Patient-Specific Phenotype-to-Genotype Ebola Virus Characterization
Biosafety, biosecurity, logistical, political, and technical considerations can delay or prevent the wide dissemination of source material containing viable virus from the geographic origin of an outbreak to laboratories involved in developing medical countermeasures (MCMs). However, once virus geno...
Autores principales: | Beitzel, Brett F., Radoshitzky, Sheli R., Di Paola, Nicholas, Brannan, Jennifer M., Kimmel, David, Caviness, Katie, Soloveva, Veronica, Yu, Shuiqing, Postnikova, Elena N., Finch, Courtney L., Liu, Hu, Prugar, Laura, Bakken, Russell, Dye, John M., Kugelman, Jeffrey R., Cunningham, James M., Sanchez-Lockhart, Mariano, Kuhn, Jens H., Palacios, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537714/ https://www.ncbi.nlm.nih.gov/pubmed/34696439 http://dx.doi.org/10.3390/v13102010 |
Ejemplares similares
-
An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021) -
Reidentification of Ebola Virus E718 and ME as Ebola Virus/H.sapiens-tc/COD/1976/Yambuku-Ecran
por: Kuhn, Jens H., et al.
Publicado: (2014) -
Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection
por: Kugelman, Jeffrey R., et al.
Publicado: (2012) -
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
por: Caì, Yíngyún, et al.
Publicado: (2018) -
Phosphatidylserine clustering by the Ebola virus matrix protein is a critical step in viral budding
por: Husby, Monica L, et al.
Publicado: (2022)